|
1
|
Scully C and Bagan J: Oral squamous cell
carcinoma: Overview of current understanding of aetiopathogenesis
and clinical implications. Oral Dis. 15:388–399. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ishida K, Tomita H, Nakashima T, Hirata A,
Tanaka T, Shibata T and Hara A: Current mouse models of oral
squamous cell carcinoma: Genetic and chemically induced models.
Oral Oncol. 73:16–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gharat SA, Momin M and Bhavsar C: Oral
squamous cell carcinoma: Current treatment strategies and
nanotechnology-based approaches for prevention and therapy. Crit
Rev Ther Drug Carrier Syst. 33:363–400. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rupaimoole R, Calin GA, Lopez-Berestein G
and Sood AK: miRNA deregulation in cancer cells and the tumor
microenvironment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ling H, Fabbri M and Calin GA: MicroRNAs
and other non-coding RNAs as targets for anticancer drug
development. Nat Rev Drug Discov. 12:847–865. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reis PP, Tomenson M, Cervigne NK, Machado
J, Jurisica I, Pintilie M, Sukhai MA, Perez-Ordonez B, Grénman R,
Gilbert RW, et al: Programmed cell death 4 loss increases tumor
cell invasion and is regulated by miR-21 in oral squamous cell
carcinoma. Mol Cancer. 9:2382010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang F, Zhao W, Zhou L, Zhang L, Liu Z
and Yu D: miR-222 regulates the cell biological behavior of oral
squamous cell carcinoma by targeting PUMA. Oncol Rep. 31:1255–1262.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen L, Liu L, Ge L, Xie L, Liu S, Sang L,
Zhan T and Li H: miR-448 downregulates MPPED2 to promote cancer
proliferation and inhibit apoptosis in oral squamous cell
carcinoma. Exp Ther Med. 12:2747–2752. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu T, Liu K, Wu Y, Fan J, Chen J, Li C,
Yang Q and Wang Z: MicroRNA-9 inhibits the proliferation of oral
squamous cell carcinoma cells by suppressing expression of CXCR4
via the Wnt/β-catenin signaling pathway. Oncogene. 33:5017–5027.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan B, Fu Q, Lai L, Tao X, Fei Y, Shen J,
Chen Z and Wang Q: Downregulation of microRNA 99a in oral squamous
cell carcinomas contributes to the growth and survival of oral
cancer cells. Mol Med Rep. 6:675–681. 2012.PubMed/NCBI
|
|
12
|
Yen YC, Shiah SG, Chu HC, Hsu YM, Hsiao
JR, Chang JY, Hung WC, Liao CT, Cheng AJ, Lu YC and Chen YW:
Reciprocal regulation of microRNA-99a and insulin-like growth
factor I receptor signaling in oral squamous cell carcinoma cells.
Mol Cancer. 13:62014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang WC, Chan SH, Jang TH, Chang JW, Ko
YC, Yen TC, Chiang SL, Chiang WF, Shieh TY, Liao CT, et al:
miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral
squamous cell carcinoma invasion and metastasis. Cancer Res.
74:751–764. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Czimmerer Z, Varga T, Kiss M, Vázquez CO,
Doan-Xuan QM, Rückerl D, Tattikota SG, Yan X, Nagy ZS, Daniel B, et
al: The IL-4/STAT6 signaling axis establishes a conserved microRNA
signature in human and mouse macrophages regulating cell survival
via miR-342-3p. Genome Med. 8:632016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Xu L, Xu M, Liu G, Xing J, Sun C
and Ding H: Obesity-associated MiR-342-3p promotes adipogenesis of
mesenchymal stem cells by suppressing CtBP2 and releasing C/EBPα
from CtBP2 binding. Cell Physiol Biochem. 35:2285–2298. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang M, Qing Y, Shi Q, Cao Y and Song K:
miR-342-3p elevates osteogenic differentiation of umbilical cord
mesenchymal stem cells via inhibiting Sufu in vitro. Biochem
Biophys Res Commun. 491:571–577. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao Y, Zhang SG, Wang ZH and Liao JC:
Down-regulation of miR-342-3p in hepatocellular carcinoma tissues
and its prognostic significance. Eur Rev Med Pharmacol Sci.
21:2098–2102. 2017.PubMed/NCBI
|
|
18
|
Xue X, Fei X, Hou W, Zhang Y, Liu L and Hu
R: miR-342-3p suppresses cell proliferation and migration by
targeting AGR2 in non-small cell lung cancer. Cancer Lett.
412:170–178. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li XR, Chu HJ, Lv T, Wang L, Kong SF and
Dai SZ: miR-342-3p suppresses proliferation, migration and invasion
by targeting FOXM1 in human cervical cancer. FEBS Lett.
588:3298–3307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roberts KP, Ensrud KM and Hamilton DW: A
comparative analysis of expression and processing of the rat
epididymal fluid and sperm-bound forms of proteins D and E. Biol
Reprod. 67:525–533. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shimizu F, Shiiba M, Ogawara K, Kimura R,
Minakawa Y, Baba T, Yokota S, Nakashima D, Higo M, Kasamatsu A, et
al: Overexpression of LIM and SH3 Protein 1 leading to accelerated
G2/M phase transition contributes to enhanced tumourigenesis in
oral cancer. PLoS One. 8:e831872013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Min A, Zhu C, Peng S, Rajthala S, Costea
DE and Sapkota D: MicroRNAs as important players and biomarkers in
oral carcinogenesis. Biomed Res Int. 2015:1869042015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi LJ, Zhang CY, Zhou ZT, Ma JY, Liu Y,
Bao ZX and Jiang WW: MicroRNA-155 in oral squamous cell carcinoma:
Overexpression, localization, and prognostic potential. Head Neck.
37:970–976. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rather MI, Nagashri MN, Swamy SS, Gopinath
KS and Kumar A: Oncogenic microRNA-155 down-regulates tumor
suppressor CDC73 and promotes oral squamous cell carcinoma cell
proliferation: Implications for cancer therapeutics. J Biol Chem.
288:608–618. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao L and Zhang Y: miR-342-3p affects
hepatocellular carcinoma cell proliferation via regulating NF-κB
pathway. Biochem Biophys Res Commun. 457:370–377. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xie X, Liu H, Wang M, Ding F, Xiao H, Hu
F, Hu R and Mei J: miR-342-3p targets RAP2B to suppress
proliferation and invasion of non-small cell lung cancer cells.
Tumour Biol. 36:5031–5038. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tai MC, Kajino T, Nakatochi M, Arima C,
Shimada Y, Suzuki M, Miyoshi H, Yatabe Y, Yanagisawa K and
Takahashi T: miR-342-3p regulates MYC transcriptional activity via
direct repression of E2F1 in human lung cancer. Carcinogenesis.
36:1464–1473. 2015.PubMed/NCBI
|
|
29
|
Tomasetto C, Moog-Lutz C, Régnier CH,
Schreiber V, Basset P and Rio MC: Lasp-1 (MLN 50) defines a new LIM
protein subfamily characterized by the association of LIM and SH3
domains. FEBS Lett. 373:245–249. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Orth MF, Cazes A, Butt E and Grunewald TG:
An update on the LIM and SH3 domain protein 1 (LASP1): A versatile
structural, signaling, and biomarker protein. Oncotarget. 6:26–42.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Grunewald TG, Kammerer U, Winkler C,
Schindler D, Sickmann A, Honig A and Butt E: Overexpression of
LASP-1 mediates migration and proliferation of human ovarian cancer
cells and influences zyxin localisation. Br J Cancer. 96:296–305.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grunewald TG, Kammerer U, Schulze E,
Schindler D, Honig A, Zimmer M and Butt E: Silencing of LASP-1
influences zyxin localization, inhibits proliferation and reduces
migration in breast cancer cells. Exp Cell Res. 312:974–982. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chiyomaru T, Enokida H, Kawakami K,
Tatarano S, Uchida Y, Kawahara K, Nishiyama K, Seki N and Nakagawa
M: Functional role of LASP1 in cell viability and its regulation by
microRNAs in bladder cancer. Urol Oncol. 30:434–443. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zheng J, Wang F, Lu S and Wang X: LASP-1,
regulated by miR-203, promotes tumor proliferation and
aggressiveness in human non-small cell lung cancer. Exp Mol Pathol.
100:116–124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao L, Wang H, Liu C, Liu Y, Wang X, Wang
S, Sun X, Li J, Deng Y, Jiang Y and Ding Y: Promotion of colorectal
cancer growth and metastasis by the LIM and SH3 domain protein 1.
Gut. 59:1226–1235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang N, Jiang X, Chen Z, Song X, Wu L,
Zong D, Song D, Yin L, Wang D, Chen C, et al: MiR-203a-3p
suppresses cell proliferation and metastasis through inhibiting
LASP1 in nasopharyngeal carcinoma. J Exp Clin Cancer Res.
36:1382017. View Article : Google Scholar : PubMed/NCBI
|
